Mrs. Martha J Pineiro is a pharmacist who is specialized in Oncology in Dallas, Texas. Patients can reach her at 3535 Worth St Ste 500, Dallas or contact her on 214-370-1547. Active license number of Mrs. Martha J Pineiro is 32463 for Oncology in Texas. Mrs. Martha J Pineiro is a licensed pharmacist who has demonstrated specialized knowledge and skill in developing, recommending, implementing, monitoring, and modifying pharmacotherapeutic plans to optimize outcomes in patients with malignant diseases.
Complete Profile:
Mrs. Martha J Pineiro speciality, credentials, practice address, contact phone number and fax are as below. Patients can call on the below given phone number for enquiries.
Name:
Mrs. Martha J Pineiro
Specialization:
Oncology
Credentials:
RPH
Gender:
Female
Location:
3535 Worth St Ste 500, Dallas, Texas, 75246-2006
Phone:
214-370-1547
Fax:
214-370-1512
Professional Identification Codes:
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details of Mrs. Martha J Pineiro are as mentioned below.
NPI Number:
1417028770
NPI Enumeration Date:
10 Nov, 2006
NPI Last Update On:
08 Jul, 2007
Medical Licenses:
Pharmacists can have one or more medical licenses for different specialities in the same state or different states. Related medical licenses for Mrs. Martha J Pineiro are as mentioned below.
Specialization
License Number
State
Status
Oncology
32463
Texas
Primary
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address:
6397 Bluffview Dr, Frisco, Texas
Zip:
75034-7255
Phone Number:
972-987-8135
Fax Number:
--
Patients can reach Mrs. Martha J Pineiro at 3535 Worth St Ste 500, Dallas, Texas or can call on phone at 214-370-1547.
Comments/ Reviews:
*Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 11 November, 2024.